Evaluating the efficacies of maximum tolerated dose and metronomic chemotherapies: a mathematical approach
From MaRDI portal
Publication:1619565
DOI10.1016/j.physa.2016.03.019zbMath1400.92257MaRDI QIDQ1619565
Rafael T. Guiraldello, Paulo F. A. Mancera, Marcelo L. Martins
Publication date: 13 November 2018
Published in: Physica A (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/11449/161543
35Q92: PDEs in connection with biology, chemistry and other natural sciences
92C45: Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.)
92C50: Medical applications (general)
35K51: Initial-boundary value problems for second-order parabolic systems
Related Items
Cites Work
- Unnamed Item
- On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
- Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: mimicking a clinical study
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
- Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response
- Modeling the Impact of Anticancer Agents on Metastatic Spreading
- Mathematical model of cancer growth controled by metronomic chemotherapies
- Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies
- TUMOR ANGIOGENESIS BASED ANALYTICAL MODEL FOR THE ASSESSMENT OF MCT AND MTD CHEMOTHERAPEUTIC STRATEGIES IN CANCER